Coordinate spending so that new health technologies for national programmes are assessed on evidence before being promoted and spread, with person-centred, informed investment decisions. Outputs include a voluntary guideline on global interoperability standards, guidance on digital hospitals, digital clinical trials and digital therapeutics, and recommendations on pseudonymisation and anonymisation.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.